Enhanced FcαRI-mediated neutrophil migration towards tumour colonies in the presence of endothelial cells (Q39358478)

11 September 2017

title

Enhanced FcαRI-mediated neutrophil migration towards tumour colonies in the presence of endothelial cells (English)

1 reference

11 September 2017

0 references

Marjolein van Egmond

0 references

author name string

Marielle A Otten

1 reference

11 September 2017

Jantine E Bakema

1 reference

11 September 2017

Cornelis W Tuk

1 reference

11 September 2017

Martin J Glennie

1 reference

11 September 2017

Alison L Tutt

1 reference

11 September 2017

Robert H J Beelen

1 reference

11 September 2017

Jan G J van de Winkel

1 reference

11 September 2017

language of work or name

English

0 references

publication date

1 July 2012

1 reference

European Journal of Immunology

11 September 2017

published in

1 reference

11 September 2017

1 reference

11 September 2017

1 reference

11 September 2017

page(s)

1815-1821

1 reference

Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2).

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141982

Neutrophils in the activation and regulation of innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141982

T helper 17 cells promote cytotoxic T cell activation in tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141982

Immature neutrophils mediate tumor cell killing via IgA but not IgG Fc receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141982

Triggering Fc alpha-receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141982

Differential effect of cytokine treatment on Fc alpha receptor I- and Fc gamma receptor I-mediated tumor cytotoxicity by monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141982

IgA antibodies for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141982

Chimeric IgA antibodies against HLA class II effectively trigger lymphoma cell killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141982

Effector mechanisms of recombinant IgA antibodies against epidermal growth factor receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141982

Recombinant human monoclonal igA antibody against CEA to recruit neutrophils to CEA-expressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141982

Recombinant dimeric IgA antibodies against the epidermal growth factor receptor mediate effective tumor cell killing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141982

Targeting FcαRI on Polymorphonuclear Cells Induces Tumor Cell Killing through Autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141982

Immunoglobulin A: Fc(alpha)RI interactions induce neutrophil migration through release of leukotriene B4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141982

Immunoglobulin A: A next generation of therapeutic antibodies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141982

Functional Association between the Human Myeloid Immunoglobulin A Fc Receptor (CD89) and FcR [IMAGE] Chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141982

Fc receptor gamma chain residues at the interface of the cytoplasmic and transmembrane domains affect association with FcalphaRI, surface expression, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141982

A common site of the Fc receptor gamma subunit interacts with the unrelated immunoreceptors FcalphaRI and FcepsilonRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141982

Signaling through mutants of the IgA receptor CD89 and consequences for Fc receptor gamma-chain interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141982

FcR gamma-chain dependent signaling in immature neutrophils is mediated by FcalphaRI, but not by FcgammaRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141982

Leukotriene B4-induced changes in vascular permeability are mediated by neutrophil release of heparin-binding protein (HBP/CAP37/azurocidin).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141982

Differential induction of BLT receptor expression on human endothelial cells by lipopolysaccharide, cytokines, and leukotriene B4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141982

Evidence for a cross-talk between human neutrophils and Th17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141982

Anti-tumor effect of inflammatory neutrophils: characteristics of in vivo generation and in vitro tumor cell lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141982

7 January 2021

Antitumor effect of locally produced CD95 ligand

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141982

7 January 2021

Activated neutrophils as effector cells for bispecific antibodies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141982

7 January 2021

Leukotriene B4-activated human endothelial cells promote transendothelial neutrophil migration

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141982

7 January 2021

Proceedings of the 4th International Conference on Bispecific Antibodies. Duck Key, Florida, March 1-5, 1995

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141982

7 January 2021

Rapid fluorescence-based measurement of neutrophil migration in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141982

7 January 2021

Identifiers

DOI

10.1002/EJI.201141982

1 reference

11 September 2017

1 reference